This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
CRD COMMENTARY -Selection of comparators
The comparison of the improved pathway to both the 'old' pathway and usual care is a realistic comparison, as this is how patients would be treated in actual practice.
Validity of estimate of measure of benefit
The measure of benefit was probably adequate from the viewpoint of the hospital, but may have been improved by looking at other issues of quality of care and quality of life.
Validity of estimate of costs
Costs were not, unfortunately, reported in actual dollar terms. This makes it impossible to assess the face validity of the cost figure behind the relative charge data. Further, the use of charges instead of costs, or even the use of a cost/charge ratio, would have improved the study. The use of the relative charge as the measure of cost also makes it impossible to calculate a cost-effectiveness ratio. This may not be too strong a concern, however, as the pathway (Group III) appears to be dominant with regard to the length of stay outcome (i.e. it costs less and lowers length of stay). With the other outcomes of mortality and readmission rates, there appears to be no difference in outcome, but there is an improvement in relative charges. Again, one would choose the pathway followed by Group III. Probably the are of most concern in this study is the lack of information regarding the resources included in the costing. The decision not to include the salary of the case manager may have been ill-advised, but the authors state that the impact would have been small. It is rather difficult to assess the generalizability and reliability of the study without more information regarding the costs and resources used. A related concern is that p-values are reported for the relative charges from the 3 groups, but it is not clear what test was used or whether the charges themselves were tested or their relative rankings. This is an important limitation because testing for differences between relative charges is different than testing for differences between the actual charges and may yield different p-values, leading to different conclusions. It should be noted that hospital policy was followed in publishing the charge data in relative terms.
Other issues
This study most closely resembles a cost-minimization analysis, but there are some demonstrated differences in outcomes in the study groups. It should be noted that the data is never expressed in terms of a ratio, and further, costs are always expressed in percentage terms, making a cost-effectiveness ratio impossible to calculate.
